Research advances in cord blood cytokine induced killer cells
Qiong Xiao
Abstract
Qiong Xiao
Abstract
Cytokine induced killer (CIK) cells are immune effector cells generated from mononuclear cells induced by many cytokines. CIK cells have several advantages, such as rapid proliferation, broad spectrum killing activity, high tumoricidal activity and non-major histocompatibility complex restriction. Recently, cord blood derived CIK cells have attracted extensive concerns because of its faster proliferation, higher tumoricidal activity and lower incidence of GVHD compared with adult peripheral blood derived CIK cells. This paper will review the biological characteristics, clinical application and research advances of cord blood derived CIK cells. Key words: Cord blood; Cytokine induced killer cells; Immunotherapy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cytokine induced killer (CIK) cells are immune effector cells generated from mononuclear cells induced by many cytokines. CIK cells have several advantages, such as rapid proliferation, broad spectrum killing activity, high tumoricidal activity and non-major histocompatibility complex restriction. Recently, cord blood derived CIK cells have attracted extensive concerns because of its faster proliferation, higher tumoricidal activity and lower incidence of GVHD compared with adult peripheral blood derived CIK cells. This paper will review the biological characteristics, clinical application and research advances of cord blood derived CIK cells. Key words: Cord blood; Cytokine induced killer cells; Immunotherapy
Key concepts: Cytokine-induced killer cell, Medicine, Cord blood, Peripheral blood mononuclear cell, Immunology, Cytokine, Immune system, Immunotherapy